Select Page
Rophe Pharma’S New Product Aims At The Hair Growth Market

Rophe Pharma’S New Product Aims At The Hair Growth Market

Robert Gadimian, owner of Rophe Pharma, announces his company has applied for the International Patent Application (PCT application) for RPHE-7193, which is a topical drug for the treatment of hair loss. Hydralazine, the active substance in RPHE-7193, was approved...